Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Exp Dermatol ; 28(4): 360-3, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12823291

RESUMO

Six patients with extramammary Paget's disease were treated with curative intent radiotherapy. Two of the patients had associated underlying adenocarcinoma. Radiotherapy was given as primary treatment (two patients), definitive treatment for postexcisional relapse (three patients) and adjuvant treatment (one patient). Radiotherapy techniques included high dose rate mould brachytherapy, electron beam, superficial X-ray and photon treatments. Follow-up durations after radiotherapy were 1.2-14.8 years. Complete response was obtained in five patients while one patient had a partial response. Marginal failure occurred in one complete-responder who was successfully salvaged by surgery. The two patients with underlying adenocarcinoma died of distant metastasis. Radiotherapy side effects were acute confluent wet desquamation and mild late skin atrophy. Our results confirmed the useful role of radiotherapy in the management of extramammary Paget's disease.


Assuntos
Neoplasias Abdominais/radioterapia , Adenocarcinoma/radioterapia , Neoplasias dos Genitais Masculinos/radioterapia , Doença de Paget Extramamária/radioterapia , Neoplasias Vulvares/radioterapia , Adulto , Idoso , Braquiterapia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Doses de Radiação , Radioterapia/efeitos adversos , Falha de Tratamento
2.
Clin Oncol (R Coll Radiol) ; 10(3): 161-4, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9704177

RESUMO

Six hundred and ninety-three Chinese patients with non-metastatic nasopharyngeal carcinoma (NPC) were treated at one institution under a uniform protocol between 1984 and 1989. The tumour histology of these patients was subjected to a standardized review and classified into two distinct groups of World Health Organization (WHO) type I (keratinizing squamous cell carcinoma) (n = 13) or WHO types II and III (non-keratinizing carcinoma and undifferentiated carcinoma) (n = 662). The differentiation between the two groups was uncertain in 18 patients. The patient characteristics and clinical outcome after a uniform treatment policy of the two groups were not statistically significantly different. The low incidence of WHO type I NPC may account for the lack of prognostic significance of this histological subtype in Chinese populations.


Assuntos
Carcinoma de Células Escamosas/patologia , Carcinoma/patologia , Neoplasias Nasofaríngeas/patologia , Análise Atuarial , Biópsia , Carcinoma/classificação , Carcinoma/radioterapia , Carcinoma/secundário , Carcinoma in Situ/classificação , Carcinoma in Situ/patologia , Carcinoma in Situ/radioterapia , Carcinoma in Situ/secundário , Carcinoma de Células Escamosas/classificação , Carcinoma de Células Escamosas/radioterapia , Carcinoma de Células Escamosas/secundário , Intervalos de Confiança , Intervalo Livre de Doença , Feminino , Humanos , Incidência , Radioisótopos de Irídio/uso terapêutico , Queratinas , Masculino , Pessoa de Meia-Idade , Neoplasias Nasofaríngeas/classificação , Neoplasias Nasofaríngeas/radioterapia , Recidiva Local de Neoplasia , Razão de Chances , Prognóstico , Modelos de Riscos Proporcionais , Compostos Radiofarmacêuticos/uso terapêutico , Dosagem Radioterapêutica , Taxa de Sobrevida , Resultado do Tratamento , Organização Mundial da Saúde
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA